NASDAQ:ADAP
Adaptimmune Therapeutics plc Stock News
$1.06
-0.0200 (-1.85%)
At Close: Apr 25, 2024
Adaptimmune Therapeutics PLC - (NASDAQ:ADAP) Receives Consensus Recommendation of "Buy" from Brokerages
07:50am, Wednesday, 25'th Mar 2020
Adaptimmune Therapeutics PLC – (NASDAQ:ADAP) has received a consensus rating of “Buy” from the nine brokerages that are currently covering the company, MarketBeat Ratings reports. Four investmen
Top Pharma Stocks Under $5
02:00pm, Tuesday, 24'th Mar 2020
These clinical-stage drugmakers could be a steal at current levels.
Edited Transcript of ADAP earnings conference call or presentation 27-Feb-20 1:00pm GMT
02:40am, Saturday, 21'st Mar 2020
Q4 2019 Adaptimmune Therapeutics PLC Earnings Call
Vascular Biogenics (VBLT) Gets a Buy Rating from JonesTrading
05:18pm, Thursday, 19'th Mar 2020
JonesTrading analyst Soumit Roy reiterated a Buy rating on Vascular Biogenics (VBLT) today and set a price target of $3.75. The company's shares closed
Vascular Biogenics (VBLT) Gets a Buy Rating from JonesTrading
05:18pm, Thursday, 19'th Mar 2020
JonesTrading analyst
Soumit Roy
reiterated a
Buy
rating on Vascular Biogenics (
VBLT
–
Research Report
) today and set a price target of
$3.75
. The company’s shares closed last Monday at $0.95, c
Edited Transcript of ADAP earnings conference call or presentation 27-Feb-20 1:00pm GMT
10:43am, Thursday, 19'th Mar 2020
Q4 2019 Adaptimmune Therapeutics PLC Earnings Call
Fastest VW Golf GTI revealed
10:52pm, Monday, 16'th Mar 2020
One of Australia’s most popular hot hatches is about to get a lot more performance.
Adaptimmune Therapeutics PLC - (NASDAQ:ADAP) Short Interest Update
08:00am, Friday, 13'th Mar 2020
Adaptimmune Therapeutics PLC – (NASDAQ:ADAP) saw a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 468,800 shares, a decrease
Passage Bio's IPO tops out at $248.4M after options exercised
03:35pm, Wednesday, 11'th Mar 2020
Passage Bio Co-Founder Dr. James Wilson.
JonesTrading Keeps a Buy Rating on Deciphera Pharmaceuticals (DCPH)
12:08pm, Wednesday, 11'th Mar 2020
JonesTrading analyst Soumit Roy reiterated a Buy rating on Deciphera Pharmaceuticals (DCPH) today. The company's shares closed last Monday at $49.99.
Cowen & Co. Sticks to Its Buy Rating for Constellation Pharmaceuticals (CNST)
04:08am, Wednesday, 11'th Mar 2020
Cowen & Co. analyst Marc Frahm maintained a Buy rating on Constellation Pharmaceuticals (CNST) yesterday. The company's shares closed last Monday at
Cowen & Co. Sticks to Its Buy Rating for Constellation Pharmaceuticals (CNST)
04:08am, Wednesday, 11'th Mar 2020
Cowen & Co. analyst
Marc Frahm
maintained a
Buy
rating on Constellation Pharmaceuticals (
CNST
–
Research Report
) yesterday. The company’s shares closed last Monday at $32.41.
According to
TipRan
Surface Oncology (SURF) Gets a Buy Rating from JonesTrading
04:32pm, Monday, 09'th Mar 2020
JonesTrading analyst Soumit Roy reiterated a Buy rating on Surface Oncology (SURF) today and set a price target of $12.00. The company's shares closed
Surface Oncology (SURF) Gets a Buy Rating from JonesTrading
04:32pm, Monday, 09'th Mar 2020
JonesTrading analyst Soumit Roy reiterated a Buy rating on Surface Oncology (SURF – Research Report) today and set a price
Zacks Investment Research Lowers Adaptimmune Therapeutics (NASDAQ:ADAP) to Hold
10:40am, Saturday, 07'th Mar 2020
Zacks Investment Research downgraded shares of Adaptimmune Therapeutics (NASDAQ:ADAP) from a buy rating to a hold rating in a report published on Tuesday morning, Zacks.com reports. According to Zacks
